MathBiology proudly took part in eMerge Americas 2025, one of the most influential technology and innovation conferences in the Americas, held in Miami, Florida. The event, spanning March 27-28, brought together global leaders, startups, investors, and tech enthusiasts eager to shape the future of health technology and digital innovation.

As a participant, MathBiology showcased its cutting-edge DMA® technology, a revolutionary AI-powered, zero-invasive screening platform designed to transform early diagnostics and personalized medicine. The company engaged with key industry players, shared insights on the evolving healthcare landscape, and explored valuable partnership opportunities.

eMerge Americas provided MathBiology with a dynamic environment to highlight its mission of pioneering metabolic health diagnostics while connecting with a vibrant community of innovators and investors. This opportunity further cements MathBiology’s position as a rising leader in health tech and underscores its commitment to improving patient outcomes through advanced technology.

With Miami’s strategic location as a gateway between the Americas, the event also opened doors for MathBiology to expand its influence across North and South America, fostering collaborations that will drive the next wave of breakthroughs in biosciences and medtech.